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Preface 
 
 Biological functions are operated and controlled by sophisticated biomolecular systems. 
The function of these kind of biomolecules, especially, proteins have been attracted much attention. 
In this reason, as the proverb “Seeing is believing” says, target protein have been labeled with some 
probe to visualize the protein directly under physiological condition. 
 
 Fluorescent imaging is widely used for this purpose because of the high detection 
sensitivity and resolution. For fluorescent labeling of the target protein in living cells, there are two 
kind of the general strategy. The one is fluorescent protein which is introduced to the target protein 
by genetically engineering method. Although specific and stable labeling is promised by using the 
fluorescent protein, the large molecular weight sometimes interfere the target protein function. The 
other is small chemical probes. The labeling with small chemical probes minimizes the obstruction 
for target protein, however, specificity and stability of the protein labeling is still remaining as a 
challenging study. 
 
 This thesis is summarized the strategy for construction of functional small chemical probes. 
It was found that functionalization of small chemical probes was enabled by utilization of the 
molecular interaction. The author is convinced this thesis would be benefit and contribute to the 
technology of protein labeling. 
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1. Fluorescent Proteins for Labeling of a Target Protein 
 Fluorescent proteins, e.g., the green fluorescent protein, can serve as a marker for the 
genetically engineered protein, because its fluorescence can be specifically monitored and it is a 
stable label
1
. Therefore, fluorescent proteins have become essential tools for studying the 
localization, dynamics, and interactions of proteins with living cells. Additionally, functionalized 
fluorescent proteins, e.g. Keima
2
 which is converted from green to red emission by UV irradiation, 
and Dronpa
3,4
 which is reversibly regulated their fluorescence emission by UV and blue light 
irradiation, are developed and used for various applications. Especially, these kinds of the 
photocontrollable fluorescent proteins were used for super-resolution imaging by utilizing 
photoactivated localization microscopy (PALM)
5
 and stochastic optical reconstruction microscopy 
(STORM)
6
. 
 
2. Enzymatic Protein Labeling with Small Molecular Fluorescent Probes 
 Small molecular fluorescent probes have advantage about their fluorescent protein labeling 
owing to their size which allow minimizing the obstruction to the target protein functions. 
Additionally, their variety of the functions, e.g. detection of the bio-molecules or intracellular 
environment, is also important for this purpose. However, these small molecular fluorescent probes 
are not genetically encoded like fluorescent protein. In this reason, strategy for specific labeling of 
the small molecular fluorescent probes by utilization of peptide-tag has been reported
7
. One of the 
peptide-tag labeling was performed by utilization of enzymatic reaction. In some cases, unnatural 
peptide-tags were recognized by appropriate enzyme to modify the peptide-tag, thereby specific 
introduction of the fluorescent probes was achieved as shown in Figure 1.  
 
 - 3 - 
 
Peptide tag
Fluorophore
Target protein
Enzyme  
Figure 1. Schematic illustration of enzyme-catalyzed labeling with small molecular fluorescent 
probes. 
 
As a peptide-tag for enzyme-catalyzed labeling of small fluorophore, Sortag
8
, Q-tag
9
, 
A1(GDSLDMLEWSLM)/S6(GDSLSWLLRLLN)
10
, biotin ligase acceptor peptide (AP)
11
 and 
lipoic acid ligase acceptor peptide (LPA)
12
 were reported and summarized in Table 1. Although 
these kind of specific labeling were successfully achieved, almost of these systems were limited 
their application to living cell due to the limitation of the accessibility of the enzyme and lack of the 
fluorogenic property. Indeed, application of the intracellular protein labeling is limited to LAP and 
most of the labeling was performed focused on the membrane proteins. 
 
Table 1. Enzymatic elaboration of peptide-tag for specific protein labeling. 
peptide-tag Enzyme Size of peptide-tag (aa) Kinds of labeled proteins
Sortag Sortade A 6 Membrane
Q-tag Transglutaminase 7 Membrane
A1/S6 AcpS or Sfp PPTases 11 Membrane
AP Biotin ligase 15 Membrane
LAP Lipoic acid ligase 12-17 Membrane and intracellular
 
 
3. Non-Enzymatic Protein Labeling with Small Molecular Fluorescent Probes 
 On the other hands, direct labeling of the peptide-tag without enzyme has also been 
reported by a few groups. The schematic concept is shown in Figure 2. This direct labeling 
simplifies the labeling procedure compared to the enzymatic labeling. Four types of the 
combination of a peptide-tag and small molecular fluorescent probe have been reported so far. 
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Chemical structures and application of the fluorescent probes were summarized in Figure 3 and 
Table 2
13-18
.  
 
Fluorophore
Labeling by the molecular 
recognition or reaction 
Recognition 
molecule
Peptide tag
Target protein
 
Figure 2. Schematic illustration of direct labeling with small molecular fluorescent probes. 
 
Oligo-aspartateTetra-cystein
O
N
N
N
N
NN
Zn
2+
N
H
H
N
O
Zn
2+
Asp Asp Asp Asp
FlAsH
O
As
O
S S
O-
COOH
As
S S
Cys
Cys
Cys
Cys
XaaXaa
Oligo-histisdine
N
O
O-
O-
O-
O
O
Ni
2+
HN
His His His His
ON NH
COOH
BB
Ser
Ser
Ser
Ser
XaaXaa
Tetra-serine
 
Figure 3. Four types of peptide-tag and the recognition molecule with fluorophore. 
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Table 2. Non-enzymatic labeling of peptide-tag for specific protein labeling. 
peptide-tag Fluorogenicity Size of peptide-tag (aa) Kinds of labeled proteins
TetraCys Yes 6-10 Membrane and intracellular
HexaHis No 6-10 Membrane
PolyAsp No 8-12 Membrane
TetraSer Yes 6-10 Membrane
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1. Introduction 
Novel methods to screen chemical libraries with huge diversity have been developed in the 
fields of catalysis, material science and medicinal chemistry
1
. In the area of drug discovery, 
significant efforts are being devoted to identifying ligands with high affinity for biological targets
2
. 
Recently, it has been proposed that classifying ligands in terms of dissociation constant (KD) as well 
as kinetic parameters (kon and koff) will significantly contribute to the drug screening. More 
specifically, the dissociation rate constant, off-rate (koff), is generally considered an effective 
parameter for predicting the pharmacological effect of a drug candidate
3
. 
To date, a Biacore instrument employing surface plasmon resonance has been a powerful 
tool for the measurement of kon and koff of the ligand-target binding in solution
4
. However, this 
method is not practical for high-throughput applications and has limited use in primary screening
5
. 
Recently, electrospray ionization mass spectrometry (ESI-MS) has attracted attention as a potential 
tool for label-free screening in a high-throughput format
6
. This strategy has already been 
implemented in catalyst screening through the investigation of reaction intermediate species
7
. Such 
an approach allows a readout of ligand-target non-covalent interactions from a pooled library 
without the need to purify each ligand
8
. The relationship between the stability of the ligand-target 
non-covalent complex in gas phase and the dissociation constant in solution was examined by using 
a collision activated dissociation (CAD) method based on ion trap ESI-MS
9
. However, the 
relationship between the stability in gas phase and kinetic parameters (kon and koff) in solution 
remains ambiguous. 
In this chapter, a convenient mass spectrometric screening method to select ligands that 
bind to a target molecule with lower off-rates was proposed. This method was demonstrated in 
screening ligands which favor a versatile hexahistidines tag (His-tag)
10
. The ligands to the His-tag 
are widely used in affinity chromatography to purify His-tagged proteins. Nitrilotriacetic acid 
(NTA) is capable of recognizing two imidazolyl rings of histidine units with one nickel ion in 
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between. According to the simple cooperative effect theory, multiple NTA moieties grafted to a 
scaffold have higher affinity to His-tag than mono-NTA
11
. Therefore, scaffolds bearing two or three 
NTA moieties, so-called bis- or tris-NTA ligands, have been intensively studied
12
. There are, 
however, few reports optimizing the structure of the multiple NTA ligands. Even bis-NTA ligands 
reported previously did not show the anticipated strong cooperative effect
13
. The three dimensional 
structure of the His-tag in solution is difficult to determine due to the short amino acid sequence. 
Hence, it is not easy to computationally design the multiple NTA ligands with high affinity that 
comprise a scaffold and spacer. 
 
2. Experimental Section 
ESI-MS CAD experiment with ion trap 
For evaluation of the stability of non-covalent complex, mass spectrometric studies were 
performed in the negative ion mode using LCQ Fleet mass spectrometer (Thermo Fisher Scientific, 
USA).  The capillary temperature was kept at 200 
o
C. A sample solution was injected into the 
source of the mass spectrometer with a syringe pump at a flow rate of 10 l /min. The spray voltage 
was set to 4 kV. The ESI-MS spectra were averaged over 10 scans for high reproducibility. The 
desirable peak corresponding to the complex (scan range from 600–2000 m/z) was isolated in the 
range of 5 m/z for more effective ion detection. Helium served as the collision gas. For collection of 
the collision profiles with increase of collision energy, the trapped ion was activated in CAD mode 
by increasing the collision energies (in 1% increments from 12–24% of the maximum available from 
a 5-V tickle voltage).   
 
Biacore analysis 
Analyses for kinetic parameters were performed by Biacore X-100 (GE Healthcare) with 
Sensor Chip SA (GE Healthcare). Biotin-GHHHHHH peptide (Biotin-His) was immobilized onto 
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Sensor Chip SA via biotin-streptavidin interaction. First, 1.25 M Biotin-His in running buffer 
(Tris-HCl: 20 mM, NaCl: 200 mM, Tween 20: 0.005 %, pH: 7.4) was injected to the flow path 2 in 
the chip (10 l / min, 100 sec).  A series of bis-NTA ligands (f{2,4}, f{3,3}, g{3,3}, f{3,4}, m{3,3}, 
h{3,3}, t{3,3}, amino-f{2,4}, and tris-NTA) preloaded with nickel ions were injected sequentially 
by five concentrations (0.625, 1.25, 2.5, 5.0, 10 M) to sensor chip. The kinetic parameters were 
assessed with single cycle kinetics mode in Biacore X-100 and obtained sensorgram (Resonance Unit 
vs. time) was curve fitted by 1:1 binding mode with BiaEvaluation (GE Healthcare). Sensor Chip 
was regenerated with 3 mM EDTA in running buffer. 
 
ITC analysis 
Isothermal titration calorimetric measurements were performed with NANO ITC (TA 
instruments). All chemicals were dissolved in Tris buffered saline (Tris: 20 mM, NaCl: 200 mM) 
and all thermograms were acquired at 20 
o
C.  First, the 950 l of 90 M bis-NTA ligands (f{2,4}, 
f{3,3}, g{3,3}, f{3,4}, m{3,3}, h{3,3}, and t{3,3} ) was filled in a sample cell. Then, the 10 l of 600 
M hexhahistidine (His) was titrated isothermally over 300 sec intervals to the sample cell. 
Reaction mixture was kept stirring at 300 rpm by the syringe to allow rapid interaction. The acquired 
data was analyzed using Nano analyze software (TA instruments). Stoichiometric number (n), 
binding entrapy change H and dissociation constant KD were determined as all parameters are 
independent. Gibbs free energy G and binding entropy change S were calculated by the equations 
below. 
 
 
Preparation of proteins 
Male white rabbits (2.0-3.0 kg) were anesthetized by sodium pentobarbital (25 mg/kg) and 
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decapitated. Psoas muscle fibers were glycerinated immediately
21
. Actin and muscle myosin II was 
prepared from skeletal white muscle of back and leg of rabbit
22
. Actin filaments were labeled with 
rhodamine-phalloidin (Rh-Ph, R-415; Molecular Probes, Eugene, OR). Heavy meromyosin (HMM) 
was prepared by chymotriptic digestion of myosin
23
 without ammonium sulfate fractionation. 
N-ethylmaleimide (NEM) (PIERCE, Rockford, IL) modified-HMM (NEM-HMM) was prepared by 
mixing HMM and NEM
24
. Myosin V constructs, his-tagged at the N terminus, were coexpressed with 
calmodulin in Sf9 insect cells and purified by coprecipitation with actin, followed by FLAG- or 
His-affinity chromatography. All procedures conformed to the “Guidelines for Proper Conduct of 
Animal Experiments” approved by the Science Council of Japan, and were performed according to 
the “Regulations for Animal Experimentation at Waseda University.” 
 
Single molecule Myosin V assay 
We prepared the stock solutions of biotin-f{2,4} (100 M, 50 mM borate buffer pH 8.3), d-biotin as 
blocking reagent (100 M, 50 mM borate buffer, pH 8.3) and NiCl2 (200 M, 50 mM borate buffer, 
pH 8.3). The 20 l of 1 M streptavidin conjugate Q-dot 655 (Q10121MP; Invitrogen) was 
incubated with 20 l of Biotin-f{2,4} and 20 l of d-biotin for 30 min at 37oC. To the mixed 
solution, 200 l of NiCl2 was added, vortexed, and concentrated by Amicon ultra-0.5 filter (14000 g, 
20min.) to remove the excess reagents. Finally, Q-dot 655 decorated with the equal amount of 
biotin-f{2,4} and biotins (molar ratio 1:1) were obtained. 500 nM myosin V molecules and 1 M 
Q-dots were mixed in Assay Buffer (25 mM KCl, 5 mM MgCl2, 1 mM EGTA and 20 mM HEPES, 
pH 7.0) and incubated for 30 min at the room temperature. Flow cells were prepared with coverslips. 
First, NEM-HMM molecules in Assay Buffer were infused, followed by wash with Assay Buffer. 
Next, Rh-Ph labelled actin filaments were infused. After washing out the non-attached actin 
filaments with Assay Buffer, myosin V-Q-dot complexes in Assay Buffer containing 1 mM ATP 
were infused. Microscopic measurements were performed with the use of the total internal reflection 
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fluorescence microscopy equipped with IX-71 (Olympus, Tokyo, Japan) at 25 ± 1 °C. The 
fluorescence images were recorded at the video rate and analyzed by Mark3 [a custom-made 
software by Dr. K. Furuta (National Institute of Information and Communications Technology, 
Hyogo, Japan)]. 
 
General methods of synthetic methods 
  All solvents were purchased from Kanto Chemical Industry Co. (Tokyo, Japan), and used as 
received.  All organic reagents were purchased from Tokyo Kasei Kogyo Co. Ltd. (Tokyo, Japan) 
and Sigma-Aldrich (USA) and used without further purification. All synthesized compounds were 
characterized by 
1
H NMR and electrospray ionization mass spectrometer (ESI-MS).  NMR spectra 
were recorded in a deuterated solvent on an OXFORD NMR AS400 (400 MHz) spectrometer. 
Electrospray ionization mass spectra (ESI-MS) were recorded on LCQ Fleet mass spectrometer 
(Thermo Fisher SCIENTIFIC, USA). Plastic sheets coated with 0.2 mm silica gel 60 with a 
fluorescent indicator (Merck, Germany) were used for thin-layer chromatography (TLC). 
 
Preparation of scaffold 
Scaffolds f, g, k, l, m, n and o were commercially available. TMS protected t was also 
commercially available. Scaffold a, b, c, d, e, h, i, j, p, q, r, and s were synthesized according to the 
previous literatures
25,26
. Typical procedure was described as follow; TMS-acetylene was conjugated 
to aromatic dibromide via Sonogashira cross coupling. Aromatic dibromide (1.00 mmol), 
ethynyltrimethylsilane (2.5 mmol), PPh3(0.07 mmol), CuI (0.0038 mmol) and Pd(PPh3)2Cl2 (0.01 
mmol) were dissolved by degassed Et2NH in sealed tube. Reaction mixture was vigorously stirred 
for 24 h - 48 h at 70 
o
C. Obtained black solution was allowed to be RT and filtered to remove solids. 
Solvent was evaporated and the crude mixture was purified by silica gel chromatography (eluent: 
hexane) to yield TMS-protected scaffold as oil. 
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Synthesis of compounds C1-C4 
H2N O
O
N
O
O
O
O
n
N3 O
O
N
O
O
O
O
n
n=1, C1
n=2, C2
n=3, C3
n=4, C4
 
According to the previous literature, four amino-NTA compounds having different carbon 
spacer were synthesized
27
. For example, the compound C2 was synthesized as follows
28
: NaN3(524 
mg, 8.06 mmol) was added to the solution of H2O (15 ml), dichloromethane (25 ml) and stirred 
vigorously for 5 min. under ice-bath. To this solution, Tf2O (455 mg, 1.61 mmol, 264 l) was dropped 
slowly and stirred for 2 hrs at RT to prepare TfN3. TfN3 was extracted with dichloromethane (25 ml x 
2) and combined organic layer was washed with saturated Na2CO3 (60 ml) to yield TfN3 in 
dichloromethane.  The amino-NTA compound (325 mg, 0.806 mmol), K2CO3 (167 mg, 1.21 mmol) 
and CuSO4 5H2O (2 mg, 0.008 mmol) were dissolved with mixture of H2O (38 ml) and methanol (60 
ml). After 5 min, TfN3 in dichloromethane was added dropwise and stirred overnight at RT. The 
volitiles were removed in vacuo.  Dichloromethane was poured and the solution was washed by 
10 % KHSO4 aq.  Inorganic layer was extracted with dichloromethane (x 2) and combined organic 
layer was washed with brine.  The organic layer was dried over Na2SO4 and evaporated to yield 
brown oil. Crude mixture was purified by chromatography on silica gel (hexane/EtOAc (6/1)) to 
yield C2 as a yellow oil (182 mg, 0.425 mmol, 53 %). 
1
H NMR (CDCl3): 3.51 (2H, m), 3.40 (4H, 
s), 3.37 (1H, t, J=9.6 Hz), 1.81 (2H, m), 1.42 (9H, s), 1.40 (18H, s). 
13
C NMR (CDCl3):  171.7, 
170.6, 81.7, 81.0, 63.0, 54.3, 48.6, 30.1, 28.4. ESI-MS m/z: 429.0 (found [M+H]
+
), 428.3 (calcd.). 
 
According to same procedure, C1, C3 and C4 were synthesized and characterized as follow. 
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Characterization of C1. 
1
H NMR (CDCl3): 3.58 (7H, m), 1.49 (9H, s), 1.46 (18H, s). 
13
C NMR 
(CDCl3): 170.6, 170.0, 82.3, 81.2, 64.9, 54.4, 51.6, 28.3, ESI-MS m/z: 414.5 (found [M+H]
+
), 415.6 
(calcd.). 
Characterization of C3. 
1
H NMR (CDCl3): 3.42 (4H, m), 3.27 (1H, t, J=7.3 Hz), 3.22 (2H, t, 
J=6.8 Hz), 1.60 (4H, m), 1.41 (27H, m). 
13
C NMR (400 MHz, CDCl3): 172.4, 170.8, 81.3, 80.8, 
65.2, 53.9, 51.5, 30.4, 28.8, 28.4, 28.3, 23.4, ESI-MS m/z: 443.9 (found [M+H]
+
), 442.8 (calcd.). 
Characterization of C4. 
1
H NMR (CDCl3): 3.42 (4H, m), 3.27 (1H, t, J=7.3 Hz), 3.22 (2H, t, 
J=6.8 Hz), 1.60 (6H, m), 1.41 (27H, m). 
13
C NMR (CDCl3): 172.4, 170.8, 81.3, 80.8, 65.2, 53.9, 
51.5, 30.4, 28.8, 28.4, 28.3, 23.4, ESI-MS m/z: 456.8 (found [M+H]
+
), 456.3 (calcd.). 
 
Preparation of sample solutions for ESI-MS-CAD. 
By using azide NTA (C1-C4) and bis-alkynes scaffold (a-p), the pooled library was 
prepared as follow. Each stock solution of C1-C4 (11 mM in THF) and that of each bis-alkynes a-p 
(11 mM in THF) were prepared. As the stock solution of catalysts for click reaction, the CuSO4 and 
sodium ascorbate stock solution (22 mM in distilled water) were prepared.  To the mixed solution 
with 50 x 3 l (0.55 x3 mol) of C1, C2, and C4 and 75 l (0.83 mol) of bis-alkynes, 30 l of 
CuSO4 (0.66 mol) and 60 l of sodium ascorbate (1.32 mol) were added and stirred overnight.  
The reaction mixture was extracted with CH2Cl2, followed by removal of the solvent under reduced 
pressure. Finally, TFA (2 ml) was added and stirred during 3 hrs at 4
o
C.  After removal of TFA 
under reduced pressure, the bis-NTA compounds of alphabet {1,1}, {1,2}, {1,4}, {2,2}, {2,4} and 
{4,4} were obtained at the same time.  According to the same protocol, the C1, C3, C4 and each 
bis-alkynes produced alphabet {1,1}, {1,3}, {1,4}, {3,3}, {3,4} and {4,4}, and the C2, C3 and each 
bis-alkynes did alphabet {2,2}, {2,3}, {3,3}.  Three reaction batches can cover 10 compounds 
about each scaffold.  For the TMS-protected scaffold such as t, K2CO3 (2.2 mol) and pyridine 
(4.4 mol) were added during the click reaction to remove TMS group29. 
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Each resulting mixture with bis-NTA compounds, i.e, “click-based pooled library” was 
dissolved in water/methanol (1/1) and the stock solution of 2.2 mM (total amounts of the scaffold) 
was prepared. The NiCl2 and hexahistidine (His) stock solutions were prepared at 20 mM and 10 
mM respectively. The 46 l (0.1 mol) of bis-NTA solution and 10 l (0.2 mol) of NiCl2 was 
mixed and incubated for 20 min. at RT. To this mixed solution, 10 l (0.1 mol) of His was added 
and incubated for 20 min. at RT to form the non-covalent ternary complex. Finally, methanol and 
water was added to the mixed solution to tune the final concentration of bis-NTA (0.5 mM, 
methanol/water (1/1)). 
 
Preparation of bis-NTA ligands. 
Synthesis for symmetric bis-NTA ligands (f{3,3}, g{3,3}, m{3,3}, h{3,3} and t{3,3})    
To the mixed solution with bis-alkynes compound (0.011 mmol) in THF (4.5 ml) and C3 (9.7 
mg, 0.022 mmol), CuSO4 5H2O (27.5 mg, 0.11 mmol), sodium ascorbate (43.6 mg, 0.22 mmol) were 
added and stirred overnight at RT.  The reaction mixture was extracted with CH2Cl2 and washed 
with 30 % ammonia solution and saline solution. The organic layer was dried over Na2SO4 and 
purified by silica-gel chromatography (eluent: CHCl3/MeOH) to yield tert-butyl protected bis-NTA 
compounds (to check the purity by ESI-MS).  Subsequently, the compounds were deprotected with 
TFA for 3 hrs at 4
o
C. After reaction, 500 l of water was added and stirred for additional 2 hrs. The 
solvent was removed under reduced pressure and residual was lyophilized from water to yield as 
white powder. The compounds f{3,3}, g{3,3}, m{3,3}, h{3,3} and t{3,3} were characterized by 
1
H 
NMR and ESI-MS as follow. 
 
Characterization of f{3,3}. 
1
H NMR (DMSO-d6):  8.60 (2H, m), 7.94 (4H, s), 4.47 (4H, m), 3.52 
(10H, m), 2.01 (4H, m), 1.64 (4H, m). ESI-MS m/z: 673.3 [M-H]
-
, 674.2 (calcd.). 
Characterization of g{3,3}. 
1
H NMR (DMSO-d6):  8.53 (2H, s), 7.84 (4H, s), 4.42 (4H, m), 
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3.40(10H, m), 2.45 (4H, m), 2.00 (4H, m). ESI-MS m/z: 673.2 [M-H]
-
, 674.2 (calcd.). 
Characterization of m{3,3}. 
1
H NMR (DMSO-d6):  7.74 (2H, s), 4.29 (4H, m), 3.42 (10H, d), 2.58 
(4H, t), 1.80-1.95 (4H, m), 1.53 (8H, m) ESI-MS m/z: 653.3 [M-H]
-
, 654.3 (calcd.). 
Characterization of h{3,3}. 
1
H NMR (DMSO-d6):  8.57 (2H, s), 8.30 (1H, s), 7.75 (2H, d), 7.49 
(1H, t), 3.44 (10H, m), 1.99 (4H, m), 1.59 (4H, m). ESI-MS m/z: 336.2 [M-2H]
2-
, 673.3 [M-H]
-
, 
674.2 (calcd.). 
Characterization of t{3,3}. 
1
H NMR (DMSO-d6):  8.39 (2H, s), 4.42 (4H, s), 3.43 (10H, m), 1.93 
(4H, t), 1.99 (4H, m), 1.59 (4H, m). ESI-MS m/z: 597.1 [M-H]
-
, 598.2 (calcd.). 
 
Synthesis for asymmetric bis-NTA ligands (f{2,4} and f{3,4}). 
To the mixed solution of bis-alkynes compound (0.6 mmol) in THF (4.5 ml), CuSO4 5H2O 
(27.5 mg, 0.11 mmol), sodium ascorbate (43.6 mg, 0.22 mmol) were added.  To the reaction 
mixture, C4 (0.030 mmol) in THF (2.0 ml) was then dropped and stirred overnight at RT.  The 
reaction mixture was extracted with EtOAc and washed with 30 % ammonia solution and saline 
solution. The organic layer was dried over Na2SO4 and purified by silica gel chromatography 
(eluent: hexane/EtOAc (2/1)) to yield mono-NTA compounds (to confirm the molecular weight by 
ESI-MS).  Subsequently, C2 (0.030 mmol) was reacted with mono-NTA compound under same 
the catalytic condition. The crude mixture was purified by silica gel chromatography (eluent: CHCl3 
to CHCl3/MeOH (3/1)) to yield tert-butyl protected f{2.4} 6.2 mg (6.1 mol, 69 %). The solvent was 
removed under reduced pressure. The residual was dissolved in TFA (2 ml) and the solution was 
stirred for 3 hr at 4
o
C. After reaction, 500 l of water was added and stirred for additional 2 hrs. The 
solvent was removed under reduced pressure and lyophilized from water to yield f{2.4} as white 
powder. 
1
H NMR (DMSO-d6):  8.57 (2H, m), 7.87 (4H, m), 4.56 (2H, m), 4.34 (2H, m), 3.40 (10H, 
m), 2.16 (4H, m), 1.85 (4H, m). ESI-MS m/z: 673.3 [M-H
+
], 674.2 (calcd.). According to the same 
protocol, f{3,4} was synthesized and characterized as follow. 
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Characterization of f{3,4}. 
1
H NMR (DMSO-d6):  8.56 (2H, d), 7.86 (4H, m), 4.42 (2H, m), 4.34 
(2H, m), 3.43 (10H, m), 2.00 (4H, m), 1.60 (6H, m). ESI-MS m/z: 687.3 [M-H]
-
, 688.3 (calcd). 
 
Preparation of Ni-loaded bis-NTA ligands.  After deprotection of each bis-NTA, the product was 
dissolved in DMSO-d6. To determine the concentration of bis-NTA ligands by internal standard 
method, 350 l of 8 mM benzene in DMSO-d6 and 350 l of bis-NTA solution were mixed and 
proton NMR was measured. Aromatic proton of bis-NTA ligands was compared with internal 
standard proton and calculated its concentration by equation below.  
.  
Here, I: integrated intensity, H: Number of proton of interest, C: Concentration, A: bis-NTA, B: 
Benzene 
After determination of the concentration, 2.16 mmol of each bis-NTA in DMSO-d6 was 
diluted by 1 ml of 20 mM Tris buffer containing 8.64 mmol NiCl2.  The solution was incubated for 
2 hr on ice.  After complexaiton with nickel ions, the solution was diluted 5 times by additional Tris 
buffer.  Nickel coordinated complex so obtained was adsorbed to anion exchange resin (Hitrap Q, 
GE healthcare) by Tris buffer as moving phase and excess nickel cation was removed. Subsequently, 
the resulting complex was eluted by Tris buffered saline (2M NaCl). The 3 ml elution was collected 
and diluted 4 times by Tris buffer. Purified complex was used for experiment performed by ITC and 
Biacore. 
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Synthesis of biotin-f{2,4} 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 2: 2,5-dibromophenol (1) was synthesized according to a previous report
30
. 
2,5-dibromophenol (295 mg, 1.17 mmol) and triisopropylsilylacetate (1.30 ml, 5.86 mmol) were 
dissolved in degassed THF (8 ml) and pyridine (8 ml). CuI (9.7 mg, 0.051 mmol) and Pd(PPh3)2Cl2 
(25.7 mg, 0.0367 mmol) were added to the solution and stirred 20 hr at 80 
o
C.  The solvent was 
removed under reduced pressure and water was added into the reaction flask. The residue was 
extracted with EtOAc and washed with brine. After removal of the solvents, the residue was 
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subjected to column chromatography over silica gel (eluent, Hexane/EtOAc (9/1)) to give 
2,5-bis(isopropylsily)ethynylphenol 2 (212 mg, 40 %). 
1
H NMR (CDCl3) :7.27 (dd, 1H), 7.06 (dd, 
1H), 6.97 (dd, 1H), 5.84 (s, 1H), 1.15-1.12 (br, 42H). 
13
C NMR (CDCl3) :  156.9, 131.5, 125.6, 124.2, 
118.0, 110.2, 106.6, 100.8, 100.7, 93.0, 18.8, 11.5, 11.4. ESI-MS: m/z = 453.42 [M-H
+
]
-
. (calcd. 
454.3) 
 
Compound 3: 2,5-bis(isopropylsilyl)ethynylphenol 2 (212 mg, 0.466 mmol) and K2CO3 (100 mg, 
0.724 mmol) were dissolved in DMF (10 ml). 3-(Boc-amino)propyl bromide (140 mg, 0.588 mmol) 
was added into the solution and stirred 24 hrs at 60 
o
C. The solvent was evaporated in vacuo, and 
water was added into the reaction flask. The residue was extracted with EtOAc and washed with brine. 
The residue was subjected to column chromatography over silica gel (eluent, Hexane/EtOAc (9/1)) to 
give compound 3 (271 mg, 95 %). 
1
H NMR (CDCl3) : 7.33 (d, 1H), 7.00 (dd, 1H), 6.91 (s, 1H), 4.70 
(br, 1H), 4.06 (t, 2H), 3.37-3.33 (m, 2H), 2.02-1.99 (m, 2H), 1.43 (s, 9H), 1.18-1.10 (br, 42H). 
13
C 
NMR (CDCl3) :  159.6, 156.2, 133.7, 124.7, 124.6, 115.2, 113.7, 106.9, 102.9, 96.8, 92.6, 66.2, 37.7, 
29.5, 28.6, 18.9, 18.9, 11.5, 11.5. ESI-MS: m/z = 634.25 [M+Na]
+
. (calcd. 611.4) 
  
Amino-f{2,4}: Compound 3 (183 mg, 0.3 mmol) was dissolved in THF (4.5 ml) and TBAF (700 l 
of 1M solution in THF, 0.7 mmol) was added for 30 min. at RT., followed by addition of CuSO4 
5H2O (27.5 mg, 0.11 mmol) and sodium ascorbate (43.6 mg, 0.22 mmol). To the reaction mixture, 
C4 (13.7mg, 0.030 mmol) in THF (2.0 ml) was then dropped and stirred overnight at RT.  The 
reaction mixture was extracted with EtOAc and washed with 30 % ammonia solution and saline 
solution. The organic layer was dried over Na2SO4 and purified by silica-gel chromatography 
(hexane/EtOAc (1/1)) to yield mono-NTA compounds (to confirm the molecular weight by ESI-MS).  
Subsequently, C2 (12.8 mg, 0.030 mmol) was reacted with mono-NTA compound under the same 
condition but without TBAF. The crude mixture was purified by silica-gel chromatography (CHCl3 
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to CHCl3/MeOH (20/1)) to yield compound 4 (20.8 mg, 59 %). ESI-MS: m/z = 1206.5 [M+Na]
+
. 
(calcd.1183.7). The deprotection of compound 4 (10.0 mg, 8.4 mol) with TFA (2.0 ml) was 
performed for 3 hr at 4
o
C. After reaction, 500 l of water was added and stirred for additional 2 hr. 
The solvent was removed under reduced pressure and lyophilized from water to yield amino-f{2.4} 
as white powder (5.0 mg, 80 %; yield was calculated from the salt-free molecular weight). 
1
H NMR 
(DMSO-d6):  8.61 (1H, s), 8.28 (1H, s), 8.10 (2H, d), 7.60 (1H, s), 7.47 (1H, d), 4.59 (2H, t), 4.35 
(2H, t), 4.28 (2H, t), 4.16 (2H, m), 3.45 (10H, m), 2.13 (2H, m), 1.85 (2H, m), 1.33-1.25 (6H, m). 
ESI-MS m/z: 746.4 [M-H]
-
, 372.5 [M-2H]
2-
, 747.3 (calcd.) 
 
Biotin-f{2,4}.  The amino-f{2,4} (5.0 mg, 6.7 mol) was dissolved in DMF (2.0 ml) and 
neutralized with DIPEA (10 l). To the mixed solution, N-succinimidyl-D-biotinate (3.4 mg, 10.1 
mol) was added and stirred overnight at RT. After reaction, the solvent was removed under 
reduced pressure. The residue was purified by preparative TLC (eluent: methanol). The desirable 
compound collected from TLC was dissolved in methanol/acetonitrile. The solution was dropped 
into diethylether and the precipitate was collected and lyophilized from water (1.2 mg, 19 %). This 
compound was characterized by ESI-MS (m/z: 972.3 [M-H]
-
, 485.92 [M-2H]
2-
, 496.92 
[M-3H+Na]
2-
, 323.83 [M-3H]
3-
, 331.08 [M-4H+Na]
3-
, 973.4 (calcd.)).The compound was dissolved 
in 1.0 ml of methanol/acetonitrile (9/1) to make the stock solution. The concentration of 
biotin-f{2,4} was confirmed by HABA Biotin Quantitation Kit (Anaspec, Inc). As a result, the stock 
solution was 1.28 mM. 
 
3. Results and Discussions 
In order to collect the pooled library that contains various bis-NTA ligands in each solution, 
a synthetic approach was adopted based on the azide-alkyne Huisgen cycloaddition as a click 
reaction, called a “click-based pooled library” method14. The combination of two building blocks, 
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such as bis-terminal alkynes and NTA with one azide group, readily generates bis-NTA ligands with 
structural diversity.  The different bis-alkyne scaffolds comprise functional groups such as five or 
six aromatic rings from a to j and aliphatic chains from k to t (Figure 1A). The bis-terminal alkynes 
are commercially available or synthesized according to a simple Sonogashira reaction
15
. As a 
recognition moiety, four types of NTA with one azide group at the terminus of different spacers (C1 
to C4) were synthesized as a tert-butyl protected form as shown in Figure 1B. The combination 
with one scaffold and four azide NTAs provides ten compounds (Figure 1C). Therefore, 200 
compounds were obtained using 20 different scaffolds. The typical ESI-MS sample was prepared as 
follows; one scaffold t was reacted with C1, C2 and C4 in a single flask in the presence of copper 
and ascorbic acid in THF/water (v/v =1/1) at room temperature. After the catalyst was removed by 
extraction with CH2Cl2, tert-butyl groups were deprotected with TFA. Then the library containing 
t{1,1}, t{1,2}, t{1,4}, t{2,2}, t{2,4}, and t{4,4} was obtained in the one solution. A major advantage 
of the click reaction approach is that a simple extraction can be used to remove catalysts from the 
library, which may otherwise interfere with the ionization process.  To encompass possible 
combinations, the mixed libraries were collected so that different structures with the same 
molecular weight, such as {1,3}-{2,2}, {1,4}-{2,3} and {2,4}-{3,3}, are not produced at the same 
time. This strategy avoids the generation of complexes with the target molecule that overlap each 
other at the x axis (m/z) of Figure 2a and cannot be distinguished by ESI-MS. 
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Figure 1. Synthesis of 200 compounds for the chemical library by click chemistry.  A) To 
synthesize branched structures, bis (alkynes) from a to t were used as clickable scaffolds. B) As a 
recognition moiety, nitrilotriacetic acid (NTA) with different carbon numbers having an azide group 
at the terminus were synthesized as a tert-butyl ester protected form.  Each NTA with an azide 
group was termed as C1, C2, C3 and C4. C) The “Click” conjugation of one bis (alkynes) scaffold 
to four different azide NTAs generated ten species. The nomenclature R is from a to t and bis-NTA 
ligands were named as follows; (alphabet){m, n}. 
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Figure 2. Screening of the mixed ligands library by ion trap ESI-MS. a) Hexahistidine (His) as 
target was added to the solution containing various bis-NTA ligands (for example, t{1,1}, t{1,2}, 
t{2,2}, t{1,4}, t{2,4} and t{4,4}) preloaded with nickel ions (Ni
2+
), to form the ligand-target 
complex.  ESI-MS detects peaks corresponding to the ternary complex with His and each bis-NTA 
ligand-Ni x 2 as double negative ion charge. b) Each complex was isolated within the ion trap and 
the stability of the complex is evaluated by CAD. E1/2 was defined as the index of the stability, 
where the relative abundance of the complex (Irel) reaches 0.5. c) E1/2 from 200 bis-NTA ligands 
were divided into six categories (i.e., <16 %, 16-17 %, 17-18 %, 18-19 %, 19-20 % and >20 %), 
which were color coded.  d) Top 20 bis-NTA ligands from among the 200 library members. e) 
Chemical structure of f{2,4}. 
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In parallel with a convenient synthesis, the library was screened by means of the CAD 
method, which utilizes an ion trap equipped with ESI-MS. When the bis-NTA ligands loaded with 
an equivalent amount of NiCl2 to NTA were mixed with hexahistidine (His), the resulting 
non-covalent ternary complexes were detected as divalent negative ions in ESI-MS. For example, 
when His was added to the library pools containing t{1,1}, t{1,2}, t{1,4}, t{2,2}, t{2,4} and t{4,4}, 
six species, all of which were ternary complexes with His and two nickel ions, were detected in a 
single scan as shown in Figure 2a. Subsequently, a desirable species of the ternary complex was 
isolated by an ion trap equipped with ESI-MS within an ion trapping space. One by one, the six 
species were then subjected to an increase of collision energy with helium gas.  As the collision 
energy increases, the complex was dissociated into ionized species, i.e., the ligand and target, such 
as [t{1,1}+Ni]- and [His+Ni]-, without any problematic decomposition of the compounds. The 
decrease of the relative abundance of the complex was displayed as a collision profile (Figure 2b). 
An index of the stability of ligand-target complexes, E1/2, as it is described by Gross et al., was 
defined as an energy value where the relative abundance of the complex reached 0.5
16
. The 
magnitude of E1/2 for each of the 200 compounds shows that this value differs according to the 
structure of the bis-NTA ligand (Figure 2c).  These differences were derived from the directions of 
the NTA moieties, which is governed by their position on the terminal alkyne. This differed in terms 
of the substituted sites of the aromatic ring, such as benzene or thiophene, or the length of the 
aliphatic spacers (e.g., even or odd). Intriguingly, a single carbon difference in spacer length of the 
azide NTA changed the E1/2, despite having the same scaffold. Among the bis-NTA ligands tested, 
the asymmetric molecule, f{2,4}, derived from the combination with 1,4-ethynyl benzene f and C2 
and C4 azide NTA moieties showed the highest E1/2 (Figure 2 c-e). 
It was expected that a greater E1/2 value would reflect a higher stability of the ligand-target 
complex in solution, i.e., better ligand for His.  One must question whether evaluating 
ligand-target affinity in the gas phase using ESI-MS can be correlated with the study in the solution 
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phase.  Indeed, previous papers have discussed this problem
6,8
.  It was warned that results 
generated in the gas phase should not be applied to non-covalent complexes formed principally via 
hydrophobic interactions
17
. Nonetheless, in many cases of the non-covalent complexes which are 
easily ionized by its virtue of charged molecule, the good agreement has been confirmed
18
. 
The results of E1/2 in the gas phase were compared with the kinetic data in solution. For 
this purpose, the author individually synthesized a few bis-NTA ligands that were selected because 
they gave a broad range of E1/2 values, i.e., f{2,4} (the highest one), f{3,3}, f{3,4}, g{3,3}, h{3,3}, 
m{3,3} and t{3,3}. The kinetic parameters of each bis-NTA ligand were determined using a Biacore 
measurement based on the biotinate-hexahistidine immobilized onto an avidin-conjugated substrate. 
 
Table 1. Kinetic parameters derived from Biacore analysis. 
Entry E 1/2 /% k on/10
3M-1s-1 k off/10
-3s-1 K D/M
[a]
f {2,4} 20.2 2.1 1.3 0.6
f{3,3} 18.6 3.0 1.5 0.5
g{3,3} 17.4 4.8 2.3 0.5
f{3,4} 16.9 1.4 3.6 2.6
m{3,3} 16.3 1.6 7.7 4.8
h{3,3} 16 4.6 6.8 1.5
t{3,3} 15.4 2.2 8.1 3.6  
[a] KD = koff / kon. 
 
 - 26 - 
 
E1/2 [%]
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
0.0 
2.0 
4.0 
6.0 
8.0 
10.0 
15 16 17 18 19 20 21
k
o
n
[1
0
3
 M
-1s
-1]k
o
ff
[1
0
-3
 s
-1
]
● koff
○ kon
-150 
-130 
-110 
-90 
-70 
-50 
-30 
-10 
-34
-33
-32
-31
-30
-29
-28
-27
15 16 17 18 19 20 21
E1/2 [%]
Δ
G
[k
J
m
o
l-
1
] Δ
H
[k
J
m
o
l -1]
■ ΔG
□ ΔH
A B
 
Figure 3. The relationship between (A) E1/2 and the kinetic parameters (koff and kon) and (B) E1/2 and 
the thermodynamic parameters (ΔG and ΔH). f{2,4}(the highest E1/2), f{3,3}, g{3,3}, f{3,4}, m{3,3}, 
h{3,3} and t{3,3}, were plotted from right to left in decreasing order of the E1/2 values. 
 
Our results revealed the representative bis-NTA ligands gave koff values in good agreement 
with the order of E1/2 values. That is, the higher the stability of a complex in the gas phase, the 
lower the kinetic dissociation rate in the solution phase (Figure 3A). On the other hand, kon did not 
have the correlation with E1/2.  The lack of correlation with kon can be rationalized because the 
non-covalent complex, which has already formed in solution, is transferred into the ion trap, 
followed by evaluation in the gas phase. In addition, the trend in KD did not follow E1/2 (see Table 1).  
This observation indicates that care must be taken when evaluating the stability of a non-covalent 
complex in the gas phase evaluated by CAD because the results do not always reflect the KD. 
Furthermore, thermodynamic parameters of the ligands were also examined by isothermal 
titration calorimetry (ITC). The stoichiometry derived from the ITC titration curve was not 
one-to-one (see Table 2).This is because the stoichiometry of ligands to His-tag is complicated due 
to the existence of multiple equilibrium states, such as dimer formation by multivalent NTA 
ligands
13
. Therefore, more precise information about the binding event will be needed to confirm 
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the relationship between the E1/2 and thermodynamic parameters e.g. enthalpy and entropy (see 
Figure 3B). By contrast, the Biacore methodology only detects binding of ligand to immobilized 
target and is thereby unaffected by dimer formation of bis-NTA ligands.  Likewise, the study using 
the ion trap, which can select the desired species, is also unaffected by other complexes that may 
have formed. 
 
Table 2. Thermodynamic parameters obtained from ITC. The binding enthalpy ΔH, KD and 
stoichiometric number (n) were determined by ITC. The standard free energy ΔG was calculated 
from KD. Difference of binding entropy ΔS was calculated from ΔG and ΔH. 
Entry E 1/2 /% ΔG /kJmol
-1 ΔＨ/ kJmol-1 ΔS /JK-1mol-1 K D [M] n /-
f {2,4} 20.2 -33.4±0.4 -72.8±21.6 -144.8±80.0 1.1±0.2 0.33
f{3,3} 18.6 -30.8±0.04 -65.0±12.8 -125.3±46.6 3.3±0.1 0.93
g{3,3} 17.4 -30.2±0.2 -89.4±23.5 -216.5±86.9 4.1±0.4 0.82
f{3,4} 16.9 -30.1±0.2 -72.4±4.2 -155.0±16.0 4.3±0.4 0.9
m{3,3} 16.3 -29.6±0.3 -75.6±21.1 -168.4±51.1 5.6±0.8 0.3
h{3,3} 16.0 -28.6±0.8 -54.3±9.2 -94.3±32.1 8.5±3.0 0.61
t{3,3} 15.4 -28.7±0.4 -68.1±3.9 -144.3±15.7 7.7±1.1 0.95  
 
The relationship between the structure of the ligands and the corresponding koff values were 
also studied. The author confirmed that the substituent positions of terminal alkynes on the benzene 
scaffold, such as h, g and f (ortho-, meta- and para-, respectively), with the same spacer length {3,3} 
affected the koff values as expected (see Table 1: h{3,3}, g{3,3} and f{3,3}).  Interestingly, a 
difference of one carbon could have an effect on the koff values, despite the ligand possessing the 
same scaffold (c.f. f{2,4} vs. f{3,4} and f{3,3} vs. f{3,4}). The approach of screening a pooled 
library, with no purification process, allows the evaluation of unforeseen asymmetric ligands 
without having to synthesize the individual compound. 
In order to assess the screened ligand with lower off-rates, f{2,4}, the fluorescent probe to 
target a His-tagged protein was fabricated. The biotinate-modified f{2,4} was synthesized as shown 
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in Figure 4a and investigated the koff to His-tag. The koff was 1.0  10
-3
s
-1
, which was slightly lower 
than that of the original f{2,4} (1.3  10-3s-1). Tris-NTA ligand was also synthesized according to 
Piehler et al
12b
. and investigated the koff under the same system. As a result, the koff for tris-NTA (0.9 
 10-3s-1) was even lower than the biotinate-modified f{2,4}. This result supports the idea put 
forward by Ebright et al
12a
. who suggested that the three NTA moieties do not work efficiently to 
give a cooperative effect due to steric congestion.  
Finally, my collaborator, Dr. Suzuki tested the labeling ability of f{2,4} in a 
single-molecule myosin V movement assay to test whether a ligand with low koff works under high 
dilution conditions. Myosin V is a dimeric motor protein that transports organelles along an actin 
filament in cells
19
. At first, myosin V molecule with a His-tag at the N-terminus was prepared. 
Based on the avidin-biotin system, biotinate-modified f{2,4} molecules were immobilized onto a 
Q-dot decorated with streptavidin molecules to fabricate a fluorescent probe for His-tagged proteins. 
Then, myosin V molecules were labeled with this probe and observed them under the optical 
microscope in the presence of ATP. As shown in Figure 4b, single Q-dots moving unidirectionally 
along an actin filament was successfully observed. The average velocity (453 nm s
-1
, n=72) and the 
average run length (741 nm, n=72) are comparable to previous observations (Figure 4c and 4d)
20
. 
These single-molecule observations, which are usually performed at low concentrations of protein 
(i.e. 1-10 nM), indicate that f{2,4} possess a koff value that is low enough to label the active motor 
protein.  
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Figure 4. Observation of single myosin V molecules. a) Biotin-modified f{2,4}  b) Top left: actin 
filaments. Top right: Q-dots moving along the actin filaments. Video frames were integrated for six 
seconds. Four moving Q-dots appeared as traces (white arrows).  Bottom panel: kymograph along 
an actin filament in the top panel (*). Horizontal scale bars, 2 m. Vertical scale bar, 1 sec. c) 
Distribution of the running velocity. The thick line shows the fit to a Gaussian peaked at 453 nm s
-1
. 
d) Distribution of the run length. The thick line shows the fit to a single exponential, p(x) = 21 
exp(-x/741), where p(x) is the probability of myosin V traveling the distance x. 
 
4. Summary 
The mass spectroscopic screening method described in this chapter identified an 
asymmetric ligand with high affinity for a hexahistidine tag from a pooled library of mixed ligands 
synthesized by click chemistry.  The convenient gas phase analysis using an ion trap revealed that 
the stability of the complex in the gas phase agreed with the dissociation rate constant in solution. 
Therefore, this method opens up the possibility of performing a powerful high-throughput screening 
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of ligands for biological applications. 
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1. Introduction 
     Fluorescence imaging is an excellent way to visualize biomolecules under physiological 
conditions because it is sensitive and has great temporal/spatial resolution
1, 2
. When covalently 
bound to a genetically engineered protein, a fluorescent protein, e.g., the green fluorescent protein, 
can serve as a marker for the genetically engineered protein, because its fluorescence can be 
specifically monitored and it is a stable label
3, 4
. However, the fluorescent protein may negatively 
affect the dynamics of the genetically engineered protein as a result of its large molecular weight or 
affect the functions (e.g. localization, mobility and transport pathway) of the target protein because 
the folding of the genetically engineered protein is altered by the attached fluorescent protein
5
. 
Conversely, when a target protein is labeled with a small chemical probe, the aforementioned 
disadvantages can be circumvented. Small chemical probes have also been used to tag genetically 
engineered proteins
6-12
. Hexahistidine ((His)6) has been widely used as an affinity tag for 
purification of genetically engineered proteins
13
. Fluorescent molecules that recognize proteins 
tagged with (His)6 are convenient probes and have been used in various applications, e.g., live cell 
imaging
10,11
 and analyses of protein structure
14
. 
Recently, Higuchi et al. described a “turn-on” fluorescent probe system that target His-tagged 
proteins via binding to an intramolecular complex formed between a fluorophore and a receptor for 
(His)6
15
. This kind of “turn-on” system has the advantage that a washing step that removes probes 
that are not bound to a His-tagged protein is not necessary, which simplifies the labeling procedure. 
However, for this type of “turn-on” fluorescent probe system, the type of fluorophore that can be 
used is restricted to make an intramolecular complex between the fluorophore and the receptor for 
(His)6. To date, coumarin and fluorescein derivatives have been used as the fluorophores in this 
system
15, 16
. The selection of the fluorophore is important for, among other techniques, multicolor 
imaging, fluorescence resonance energy transfer analysis, and single molecular imaging. 
Herein, the author describes a new type of a “turn-on” fluorescent probe system that 
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includes a quencher conjugated to (His)6, that inhibits the fluorescence of the “turn-on” probe by 
binding to it in the absence of a competing (His)6-protein (Scheme 1). Quenchers have been used 
during the development of fluorogenic nucleic acid hybridization probes, e.g., molecular beacon
17
 
and strand-displacement probes
18
. In our approach, a quencher is utilized to overcome the 
restriction of fluorophore selection because the intramolecular complex to quench the fluorescence 
between the fluorophore and the receptor for (His)6 is not required. Additionally, it is also possible 
to quench the emission of the fluorophore by addition of the quencher-conjugated peptide at any 
time. 
 The general strategy, exemplified by Scheme 1, should allow us to choose among 
different combinations of fluorophores and quenchers and ligands and receptors. As diagramed, the 
fluorophore is conjugated to a receptor, and the quencher is conjugated to the ligand. If the ligand is 
also conjugated to a protein, the system is “turned on” when the quencher-conjugated ligand is 
displaced from the receptor by the ligand-conjugated protein. As proof-of-concept experiments, the 
author developed and tested the following system. For the ligand, a (His)6 was coupled to the 
quencher Dabcyl (Dabcyl-(His)6; Scheme 1b). For the receptor, fluorescent tetramethylrhodamine 
was conjugated to tris-nitrilotriacetic acid (TMR-TriNTA; Scheme 1b), which can form a complex 
with histidine in the presence of Ni
2+
. The system was tested by adding either ubiquitin or 
(His)6-ubiquitin to a solution of Dabcyl-(His)6, TMR-TriNTA, and Ni
2+
. Therefore, our immediate 
goal was to develop a system that could be used to identify a (His)6-protein by constructing a 
fluorescent probe that is turned on only when bound to the (His)6-protein. 
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Scheme 1. (a) Conceptual scheme of a “turn-on” fluorescent probe system that uses the ability of a 
(His)6-protein to displace a (His)6-quencher from a fluorescent probe. (b) Structures of the 
fluorescent probe (TMR-TriNTA) and the (His)6-quencher (Dabcyl-(His)6) used in this study.  
 
2. Experimental Section 
Materials 
H-Lys(Z)-OtBu·HCl, and NiCl2 were purchased from Kokusan Chemical (Tokyo, Japan) and 
Wako Pure Chemical Industries Ltd. (Osaka, Japan), respectively. tert-Butyl bromoacetate and 
N,N-diisopropylethylamine were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). 
5(6)-Carboxytetramethylrhodamine N-succinimidyl ester, His-tagged and untagged ubiquitin were 
purchased from Sigma-Aldrich Japan K.K. (Tokyo, Japan). Other reagents and solvents were 
purchased from Kanto Chemical Industry Co. (Tokyo, Japan) and used as received. All synthesized 
compounds were characterized by 
1
H-NMR and mass spectrometry. The NMR spectra were 
obtained using samples prepared in a deuterated solvent and were recorded using an OXFORD 
NMR AS400 (400 MHz) spectrometer. Electrospray ionization mass spectra (ESI-MS) were 
 - 37 - 
 
recorded using a LCQ Fleet (Thermo Fisher Scientific) mass spectrometer. Plastic sheets coated 
with 0.2 mm silica gel 60 (Merck & Co.) were used for thin-layer chromatography (TLC). The 
reactions were monitored by TLC. 
 
Synthesis of TMR-TriNTA 
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N-succinimidyl ester, CH2Cl2, DIPEA
2) TFA
NH2-TriNTA(t-Bu)3 TMR-TriNTA
  
    NH2-tri-NTA(t-Bu)3 was synthesized according to a previous report
19
. NH2-tri-NTA(t-Bu)3 
(21.4 mg, 0.014 mmol) and 5(6)-carboxytetramethylrhodamine N-succinimidyl ester (4.6 mg,  
0.0070 mmol) were dissolved in CH2Cl2 (1 ml). N,N-Diisopropylethylamine (DIPEA, 10 µl) was 
added to the solution, which was then stirred overnight at room temperature. Next, the solvent was 
evaporated in vacuo, and the residue was subjected to column chromatography over silica gel 
(eluent, CHCl3/CH3OH = 40:1 (v/v)) to isolate TMR-TriNTA(t-Bu)3. Then, TMR-TriNTA(t-Bu)3 
was dissolved in TFA (2 ml) and stirred overnight. The solvent was evaporated in vacuo to give 
TMR-TriNTA (5.1 mg, 42% yield). 
1
H NMR (400 MHz, D2O/DMSO) : δ  = 8.61, 8.30, 8.15, 8.10, 
7.66, 7.42 (m, 3H, ArH), 7.04 (d, 2H, ArH), 6.92–6.83 (m, 4H, ArH), 3.66–3.13(m, 28H, -COCHN-, 
-NHCH2(CH2)3CH-, -NCH2COOH), 1.87–0.76 (m, 36H, -NHCH2(CH2)3CH-, NCH3). ESI-MS : m/z 
= 467.92 [M – 3 H
+
]
3-
. 
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Synthesis of Dabcyl-(His)6 
     Dabcyl-conjugated hexahistidine (Dabcyl-(His)6) was synthesized by Fmoc solid phase 
peptide synthesis using Fmoc-His(Trt)-OH and HBTU/HOBt/NMM as the coupling reagent 
(Hayashi Kasei Co.). Deprotection was performed in DMF/piperidine (20%) or in 
TFA/EDT/thioanisole/TIS/H2O. The product was identified as Dabcyl-(His)6 by HPLC and mass 
spectrometry. 
 
Fluorescence correlation spectroscopy and fluorescence intensity distribution 
analysis-polarization 
     The dissociation constant (KD) of TMR-TriNTA/3 Ni
2+
 for His-tag was determined using data 
obtained from fluorescence correlation spectra and fluorescence intensity distribution 
analysis-polarization that had been recorded using an MF20 single-molecule fluorescence detection 
system (Olympus Optical Co.). The samples contained 10 nM TMR-TriNTA/3 Ni
2+
, 20 mM 
Tris-HCl (pH 7.4), 0.01% Triton X-100, and various concentrations of His-tagged or untagged 
ubiquitin (0.3 nM–10 µM) in the wells of a 384-well glass bottom microplate (OLYMPUS ). A 
He-Ne laser (543 nm, 150 µW) was used to detect the TMR fluorescence. The measuring time and 
the number of repeats were 10 sec and 5sec, respectively. The rotation speed of the beam scanner 
was 1800 rpm. Almost the same fluorescence intensities were detected in five measurements. KD 
was determined by fitting the data to:  
Y = (KD + [A] + [B] – (((KD + [A] + [B])
2
 – 4[A][B])
0.5
))/2[A] 
 [A] and [B] are the concentrations of TMR-TriNTA/3 Ni
2+
 and His-tagged ubiquitin, respectively. 
Y is binding degree and was estimated using an MF20 software package. In this analysis, the degree 
of polarization or a diffusion time of 0 µM and 10 µM (His)6-ubiquitin was applied to a negative 
and positive control, respectively. 
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Fluorescence measurements 
     Fluorescence spectra were recorded using an RF5300PC spectrofluorophotometer 
(SHIMADZU) under the following conditions: excitation wavelength, 500 nm; bandwidth, 5.0 nm 
for excitation and emission; quartz cell path length, 10 mm. In the fluorescence titration experiment, 
Kapp was determined by fitting the data to: 
F/F0 – 1 = (Fmax/F0 – 1)[(His)6]/(Kapp + [(His)6]) 
Fmax, F0 and F are the fluorescence intensities of TMR-TriNTA/3 Ni
2+
, TMR-TriNTA/3 
Ni
2+
/Dabcyl-(His)6 and TMR-TriNTA/3 Ni
2+
/Dabcyl-(His)6 in the presence of (His)6, respectively. 
[(His)6] is the concentration of (His)6. 
 
3.  Results and Discussions 
     The synthetic procedure for TMR-TriNTA is summarized below and greater detail is shown in 
Experimental Section. NH2-tri-NTA(t-Bu)3 was synthesized as described
19
. 
5(6)-Carboxytetramethylrhodamine N-succinimidyl ester was conjugated to the amino group of 
NH2-tri-NTA(t-Bu)3, after which the tert-butyl groups were removed by treatment with TFA to give 
TMR-TriNTA.  
     The intermolecular interaction among TMR-TriNTA, Ni
2+
, and (His)6 was assessed using 
electrospray ionization mass spectrometry (ESI-MS), which can detect noncovalent complexes that 
involve intermolecular hydrogen and coordination bonds because the soft ionization used for ESI 
does not disrupt such bonds
20–22
. A solution of CH3CN/H2O (1:1, v/v) that contained 5 µM 
TMR-TriNTA, 15 µM NiCl2, and 5 µM (His)6 was subjected to ESI-MS. The flow rate, capillary 
temperature, and spray voltage were 10 µl/min, 250°C, and 4.5 kV, respectively. CH3CN was added 
to the aqueous sample solution because the measurement of the sample dissolved in pure water was 
difficult. The resulting ESI-MS spectrum displayed peaks that could be ascribed to the 
[TMR-TriNTA + 3 Ni
2+
 + (His)6 – 9 H
+
]
3-
 (805 m/z) and [TMR-TriNTA + 3 Ni
2+
 +(His)6 – 8 H
+
]
2-
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(1207 m/z) complexes (Figure 1). These complexes were not detected when NiCl2 was omitted (data 
not shown). 
 
Figure 1. ESI-MS spectrum of a solution containing TMR-TriNTA, NiCl2, and (His)6 (molar ratio = 
1:3:1) in H2O/CH3CN (1:1, v/v).  
 
To characterize the strength of the TMR-TriNTA/3 Ni
2+
/(His)6 complex, its dissociation 
constant (KD) was determined using fluorescence correlation spectroscopy (FCS) and fluorescence 
intensity distribution analysis-polarization (FIDA-PO) in conjunction with a single-molecule 
fluorescence detection system (MF20, Olympus Optical Co.). Single molecule imaging, e.g., FCS, 
is a most useful application for the investigation of the function of a protein labeled with a 
fluorescent group under physiological conditions. The diffusion time and the degree of polarization, 
which are related to the apparent molecular size of a fluorophore, can be obtained from FCS and 
FIDA-PO, respectively. The TMR-TriNTA/3 Ni
2+
 complex was purified by anion exchange 
chromatography (HiTrap, GE Healthcare) as described
12
. The changes in diffusion time and degree 
of polarization of the TMR-TriNTA/3 Ni
2+
 complex were measured before and after addition of 
ubiquitin or (His)6-ubiquitin (Figure 2). The TMR emission intensity was stable without any 
antifade reagents. When present at final concentrations >30 nM, (His)6-ubiquitin increased the 
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diffusion time and the degree of polarization of TMR-TriNTA/3 Ni
2+
, which indicated that 
TMR-TriNTA/3 Ni
2+
 and (His)6-ubiquitin formed a complex via the (His)6-tag (KD = 210 nM). In 
the presence of ubiquitin no change in the diffusion time or the degree of polarization was seen. The 
KD of TMR-TriNTA/3 Ni
2+
 for native histidine sequences was estimated to be higher than the KD of 
(His)6-ubiquitin and closely resemble the KD of NTA/Ni
2+
 for two or three histidines (KD is about 10 
- 100 µM)
23
 because there was no cooperativity among the NTA groups for native histidine 
sequences. In this reason, the TMR-TriNTA/3 Ni
2+
 should recognize His-tag sequence more 
preferentially than native histidine sequences. 
 
 
Figure 2. Binding behavior of TMR-TriNTA/3 Ni
2+
 and (His)6-ubiquitin or ubiquitin monitored 
using (a) fluorescence correlation spectroscopy and (b) fluorescence intensity distribution 
analysis-polarization, which were recorded using a single-molecule fluorescence detection system. 
Fluorescence polarization values are given as millipolarization (mP). 
 
     The fluorescence spectrum of TMR-TriNTA/3 Ni
2+
, before and after addition of an equimolar 
amount of Dabcyl-(His)6, was recorded to determine the extent of fluorescence quenching. When an 
equimolar amount of Dabcyl-(His)6 was added to a solution of 5 µM TMR-TriNTA/3 Ni
2+
, 20 mM 
Tris-HCl (pH 7.4), the fluorescence intensity of the solution decreased to 8% of its initial value 
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(Figure 3a). The fluorescence intensity returned to a level of 44% (5.4-fold increase) after an 
equimolar amount of (His)6 was added (Figure 3b). This fluorescence enhancement indicated that 
Dabcyl-(His)6 had been partially displaced from TMR-TriNTA/3 Ni
2+
 and that an equilibrium had 
been established between the TMR-TriNTA/3 Ni
2+
/Dabcyl-(His)6 and TMR-TriNTA/3 Ni
2+
/(His)6 
complexes. Moreover, a fluorescence titration experiment with (His)6 was performed to characterize 
the apparent equilibrium dissociation constant (Kapp). The fluorescence intensity was efficiently 
increased by addition of (His)6 (f.c. 0 - 50 µM) to the solution of 5 µM TMR-TriNTA/3 
Ni
2+
/Dabcyl-(His)6. The fluorescence of the TMR was easily detected with naked eyes under UV 
light (365 nm) excitation (Figure 4). The Kapp was approximately 12 µM by fitting the data to a 
nonlinear least square. 
 
 
Figure 3. Fluorescent spectra of 5 µM TMR-TriNTA/3 Ni
2+
 in Tris-HCl (pH 7.4) (λex = 500 nm). 
(a) before and after addition of an equimolar amount of Dabcyl-(His)6, and (b) before and after 
addition of an equimolar amount of (His)6 to the Dabcyl-(His)6-containing solution of Figure 2(a).  
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Figure 4. (a) Fluorescent spectra of 5 µM TMR-TriNTA/3 Ni
2+
/Dabcyl-(His)6 in Tris-HCl (pH 7.4) 
(λex = 500 nm) by addition of (His)6 (f.c. 0 – 50 µM). (Inset) Fluorescence titration data. (b) 
Photograph of the solution of 5 µM TMR-TriNTA/3 Ni
2+
/Dabcyl-(His)6 in the absence (left) and 
presence (right) of 50 µM (His)6 under UV light (365 nm) excitation. 
 
     To confirm that Dabcyl-(His)6 had been displaced by (His)6, ESI-MS spectra of solutions 
containing 5 µM TMR-TriNTA, 15 µM NiCl2 and 5 µM Dabcyl-(His)6 without (Figure 5a) or with 
(Figure 5c) 5 µM (His)6 were acquired under the conditions described above. [TMR-TriNTA + 3 
Ni
2+
 + Dabcyl-(His)6 – 8 H
+
]
2- 
, [TMR-TriNTA + 3 Ni
2+
 + Dabcyl-(His)6 – 7H
+
]
3-
,
 
 and 
[TMR-TriNTA + 3 Ni
2+
 + Dabcyl-(His)6 – 6 H
+
]
4- 
were detected in the spectrum shown in Figure 
S3a, and, when [TMR-TriNTA + 3 Ni
2+
 + Dabcyl-(His)6 – 7H
+
]
3-
 (889 m/z) was subjected to 
collision-activated dissociation (5.0-m/z isolation band width), peaks that could be ascribed to 
Dabcyl-(His)6 and TMR-TriNTA were found (Figure 5b). After addition of an equimolar amount of 
(His)6 to the solution of TMR-TriNTA/Dabcyl-(His)6, the resulting ESI-MS spectrum contained 
peaks that were ascribed to [TMR-TriNTA + 3 Ni
2+
 + (His)6 – 8 H
+
]
2- 
, [TMR-TriNTA + 3 Ni
2+
 + 
(His)6 – 7H
+
]
3-
,
 
 and [TMR-TriNTA + 3 Ni
2+
 + (His)6 – 6 H
+
]
4-
 (Figure 5c). Peaks ascribed to (His)6 
and TMR-TriNTA were found when [TMR-TriNTA + 3 Ni
2+
 + (His)6 – 7H
+
]
3- 
(805 m/z) was 
subjected to collision-activated dissociation (5.0 m/z isolation band width; Figure 5d).  
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Figure 5. ESI-MS spectra of a solution containing TMR-TriNTA, NiCl2, and Dabcyl-(His)6 (molar 
ratio, 1:3:1) in H2O/CH3CN (1:1, v/v) (a) before and (c) after addition of an equimolar amount of 
(His)6. Collision-activated dissociation mass spectra of (b) [TMR-TriNTA + 3 Ni
2+
+ Dabcyl-(His)6 
– 9H
+
]
3- 
and (d) [TMR-TriNTA + 3 Ni
2+ 
+ (His)6 – 9H
+
]
3-
. 
 
Finally, the author measured the fluorescence intensity of a 1 µM TMR-TriNTA/3 Ni
2+
, 20 
mM Tris-HCl (pH 7.4) solution before and after sequential additions of an equimolar amount of 
Dabcyl-(His)6, ubiquitin, and (His)6-ubiquitin. The addition of Dabcyl-(His)6 decreased the 
fluorescence of the TMR-TriNTA solution to 14% of its initial intensity (Figure 6a). When ubiquitin 
was added to this mixture, there was no significant change in the fluorescent intensity during the 
3-hr standing that the fluorescence was monitored (Figure 6b). Conversely, after (His)6-ubiquitin 
was added to the solution, the fluorescence increased to 40% of the initial intensity (Figure 6c). 
Therefore, Dabcyl-(His)6 was displaced from its complex with TMR-TriNTA/3 Ni
2+
 by only 
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(His)6-ubiquitin, which enhanced the fluorescent intensity of TMR-TriNTA/3 Ni
2+
. 
 
 
Figure 6. Fluorescent spectra of 1 µM TMR-TriNTA/3 Ni
2+
 in Tris-HCl (pH 7.4) (λex = 500 nm). 
(a) before and after addition of an equimolar amount of Dabcyl-(His)6, (b) before and after addition 
of an equimolar amount of ubiquitin to the Dabcyl-(His)6-containing solution of Figure 3(a), and (c) 
before and after addition of an equimolar amount of (His)6-ubiquitin to the Dabcyl-(His)6 and 
ubiquitin-containing solution of Figure 3(b).  
 
4. Summary 
     The author constructed a novel “turn-on” fluorescent probe system for which the fluorescent 
receptor, TMR-TriNTA/3 Ni
2+
, is “turned on” when the bound quencher, Dabcyl-(His)6, is replaced 
by a (His)6-protein. By optimizing suitable combinations of receptor and ligand, similar systems 
could also be used for single molecule imaging and multicolor imaging in conjunction with 
fluorescence resonance energy transfer for the analysis of living cells. Cell applications of this 
system are described in chapter 5 including cell membrane permeability, toxicity, and non-specific 
adsorption studies. 
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1. Introduction   
  As described in chapter 3, small chemical probes are attractive labeling tool in terms of 
the size compared with a fluorescent protein. To improve the small chemical probes for the target 
protein labeling, stable labeling with covalent bond and fluorogenic property based on the 
recognition of the target protein are required. Because the covalent bond is not reversible bond, the 
covalent labeling ability to the target protein is important and suitable for tracing the target protein. 
There have been a few reports about covalent labeling with small chemical probe to the target 
protein
1-3
. Although these papers have described a concept of covalent labeling with small chemical 
probes, there has remained a restriction of their application because of the lack of the fluorogenic 
property. Here, the author describes a design and approach of the His-tagged protein covalent 
labeling with a “turn-on” fluorescent probe. 
 
2. Experimental Section 
Materials 
All solvents were purchased from Kanto Chemical Industry Co. (Tokyo, Japan), and used 
as received.  All organic reagents were purchased from Tokyo Kasei Kogyo Co. Ltd. (Tokyo, 
Japan) and Sigma-Aldrich (USA) and used without further purification. All synthesized compounds 
were characterized by 
1
H NMR and electrospray ionization mass spectrometer (ESI-MS).  NMR 
spectra were recorded in a deuterated solvent on an OXFORD NMR AS400 (400 MHz) 
spectrometer. Electrospray ionization mass spectra (ESI-MS) were recorded on LCQ Fleet mass 
spectrometer (Thermo Fisher SCIENTIFIC, USA). Plastic sheets coated with 0.2 mm silica gel 60 
with a fluorescent indicator (Merck, Germany) were used for thin-layer chromatography (TLC). 
 
Synthesis of C3C3N3-TMR 
 Synthetic procedure is shown in Scheme 1. Compound 8 was synthesized according to the 
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previous literature
4
 and experimental section of chapter 2. 
1
H NMR (400 MHz, CD3CN/D2O) : δ  = 8.26 (s, 1H, ArH), 8.16 (d, 2H, ArH), 7.97 (s, 1H, ArH), 
7.93 (s, 1H, ArH), 7.69 (s, 1H, ArH), 7.22 (d, 2H, ArH), 4.45 (t, 2H, NH2-CH2-), 4.31 (m, 4H, 
-N-CH2CH2-), 3.61-3.21 (m, 10H, -NCH2COOH, -COCHN-), 3.13 (t, 2H, -O-CH2-), 2.23 (m, 2H, 
-O-CH2-C H2-), 2.15-1.85(m, 4H, -COCHCH2-), 1.85-1.30 (m, 4H, -N-C H2CH2-). 
ESI-MS : m/z = 930.25 [M +Na
+
– 2 H
+
]
-
. 
 
8 (0.9 mg, 1 µmol) and 5(6)-carboxytetramethylrhodamine N-succinimidyl ester (1 mg, 1.9 µmol) 
were dissolved in DMF (0.1 ml). N,N-Diisopropylethylamine (DIPEA, 3 µl) was added to the 
solution, which was then stirred overnight at room temperature. Next, the solvent was evaporated in 
vacuo, and the residue was subjected to column chromatography over octadecylsilyl silica gel 
(eluent, H2O/CH3OH = 1:1 (v/v)) to isolate C3C3N3-TMR (ESI-MS : m/z = 681.17 [M + 2Na
+
– 4 
H
+
]
2-
. 
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Scheme 1. Synthetic procedure of C3C3N3-TMR. 
 
Fluorescence intensity distribution analysis-polarization 
This experiment was performed as described in chapter 3. 
 
Fluorescence measurements 
     Fluorescence spectra were recorded using an RF5300PC spectrofluorophotometer 
(SHIMADZU) under the following conditions: excitation length, 500 nm; bandwidth, 5.0 nm for 
excitation and emission; quartz cell path length, 10 mm.  
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3. Results and Discussions 
The conceptual scheme is shown in Scheme 2(a). As a fluorescent probe for covalent 
labeling of His-tagged protein, aryl azide which is one of the photo-cross linker
5
 conjugated 
nitrilotriacetic acid (NTA) derivartive (C3C3N3-TMR) was designed and synthesized (Scheme 
2(b)). The NTA derivative was selected by the result of screening described in chapter 2. Here, 
symmetric one (f{3,3}) was choose as a recognition moiety because f{3,3} has high affinity and 
easy to synthesize compared with asymmetric one. 
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Scheme 2. (a) Conceptual scheme of a “turn-on” fluorescent probe with covalent labeling ability of 
a (His)6-protein. (b) Structures of the fluorescent probe (C3C3N3-TMR) and the 
quencher-conjugated histidine peptide (Dabcyl-His6) used in this study.  
 
The binding ability of C3C3N3-TMR to His-tag moiety was evaluated using fluorescence 
intensity distribution analysis-polarization by a single-molecule fluorescence detection system 
(MF20, Olympus) (Figure 1). Although there was no change in the degree of polarization using 
untagged ubiquitin, the change in the degree of polarization was observed using His-tagged 
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ubiquitin. C3C3N3-TMR specifically binds to the His-tag sequence and the KD was estimated as 
250 nM. This result showed good agreement with the KD of f{3,3} described in chapter 2, Table 1. 
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Figure 1. Binding behavior of C3C3N3-TMR/2Ni with His-tagged ubiquitin (His-UB) or untagged 
ubiquitin (UB) by fluorescence distribution analysis-polarization (FIDA-PO) methods.  
 
 Then, the labeling yield of C3C3N3-TMR to hexahistidine (His6) was analyzed by 
measurement of electrospray ionization mass spectrosmetry (ESI-MS) depend on the time of UV 
irradiation. After the preparation of the complex of C3C3N3-TMR and His6, UV light (365nm) was 
irradiated to the complex. The samples were introduced to ESI-MS to detect the molecular weight 
of the complex. After UV irradiation, the peak of molecular weight which covalently bond to His6 
was observed and the intensity is changed depends on the irradiation time of UV light. The labeling 
yield was calculated by using the intensity of each molecular weight (Figure 2). After 33 min UV 
irradiation, the labeling yield was 38%. 
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Figure 2. Covalent labeling of C3C3N3-TMR/2Ni to hexahistidine. Labeling yield was calculated 
by ESI-MS measurement of 5 µM complex (TMR-NTA-N3/2Ni and hexahistidine) after UV 
irradiation.  
 
 To determine the labeling yield using His-tagged protein, the diffusion time was measured 
by using fluorescence correlation spectroscopy (Figure 3). The diffusion time of C3C3N3-TMR/2Ni 
(10 nM) and C3C3N3-TMR/2Ni (10 nM) with His-tagged ubiquitin (10 µM) was 144 µs and 233 
µs, respectively. The later one showed the diffusion time of His-tagged ubiquitin labeled with 
C3C3N3-TMR/2Ni. After making the complex of His-tagged ubiquitin and C3C3N3-TMR/2Ni, UV 
light (365nm) was irradiated to the sample (0 min and 20 min). Then, EDTA which is a strong 
chelator of metal ion was added to the sample. The diffusion time with or without UV irradiation 
was 174 µs and 148 µs, respectively. The diffusion time of without UV irradiation was almost same 
to the diffusion time of C3C3N3-TMR/2Ni. This result showed that in the presence of excess EDTA, 
the complex dissociated completely. On the other hand, the diffusion time with UV irradiation was 
longer than the diffusion time of C3C3N3-TMR/2Ni. The labeling yield was calculated as 33 % 
from this result and good agreement with the result of ESI-MS. 
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Figure 3. Covalent labeling of C3C3N3-TMR/2Ni to His-tagged ubiquitin. Diffusion time was 
measured by fluorescence correlation spectroscopy at various condition described in this Figure.  
 
Finally, the “turn-on” property was evaluated by using Dabcyl-His6. The fluorescence 
spectrum of C3C3N3-TMR/2Ni, before and after addition of an equimolar amount of Dabcyl-His6, 
was measured to determine the extent of fluorescence quenching (Figure 4 (a)). When an equimolar 
amount of Dabcyl-His6 was added to a solution of 1 µM TMR-TriNTA/3 Ni
2+
, 20 mM Tris-HCl 
(pH 7.4), the fluorescence intensity of the solution decreased to 23% of its initial value. The 
fluorescence intensity returned to a level of 42% (1.8-fold increase) after five times molar excess of 
His6 was added (Figure 4(b)). This fluorescence enhancement indicated that Dabcyl-His6 had also 
been partially displaced from TMR-TriNTA/3 Ni
2+
.  
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Figure 4. Fluorescent spectra of 1 µM C3C3N3-TMR/2Ni in Tris-HCl (pH 7.4) (λex = 500 nm). (a) 
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before and after addition of an equimolar amount of Dabcyl-His6, and (b) before and after addition 
of His6 to the Dabcyl-His6--containing solution of Figure 4(a).  
 
4. Summary 
 In summary, aryl azide introduced fluorescent probe was designed and synthesized, 
successfully. The result of difference of molecular weight and diffusion time before and after UV 
irradiation showed this probe was able to bind to His-tag moiety covalently. Additionally, this probe 
worked as a “turn-on” fluorescent probe by combination of quencher-conjugated histidine peptide. 
In the future, this “turn-on” fluorescent probe will applied to living cell to evaluate the usefulness of 
covalent labeling of intracellular His-tagged protein, including the cytotoxicity, cell membrane 
permeability and so on. 
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1. Introduction  
As described in chapter 3, fluorescent probes which recognize His-tag sequence are 
convenient and useful for various applications
1-4
 including the live cell imaging because of the 
generality of the His-tag sequence for purification of the target protein. However, applications for 
live cell imaging are limited to the membrane protein labeling due to the lack of the fluorogenic 
property as shown in chapter 1 (Table 2). In this chapter, the “turn-on” system which was described 
in chapter 3 was applied to living cells and evaluated by using not only His-tagged membrane 
protein but also intracellular His-tagged protein. For intracellular His-tagged protein labeling, cell 
penetrating peptide
5
 was introduced to quencher-conjugated histidine peptide to enhance the 
membrane permeability of “turn-on” fluorescent probe. This system is expected to be the low 
artificial background and have a distinct signal after binding to His-tagged protein without any 
washing procedure. 
 
2. Experimental Section 
General methods (Chemical reagents, characterization and antibodies)  
For cell study, anti-His6 monoclonal mouse antibody (His6 Ab) was purchased from Roche 
(Cat. 11922416001, Germany). Anti-mouse IgG conjugated with horseradish peroxidase (HRP) was 
from vector laboratories (Cat. PI-2000, USA). Alexa Fluor-633-goat anti-mouse IgG was from 
Molecular probes (Cat. A21050, USA). Enhanced chemiluminescence labeling (ECL) plus western 
blotting detection reagents were from Amersham (GE Healthcare, UK). Mini complete
TM
 protease 
inhibitor cocktail (PI) was from Roche (Mannheim, Germany). PVDF membranes were from 
Bio-Rad laboratories (Cat. 162-0177, USA). Phenyl-methyl-sulfonylurea-fluoride (PMSF) and 
p-formaldehyde were from Sigma (Cat. P7626, P6148, USA).  
 
Plasmid construction 
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His-pDisplay was constructed by replacing a DNA fragment encoding for hexahistidine 
residues with the sequence between SmaI and SacII sites in pDisplay (Invitrogen,USA) and the 
strategies as follows. In the first round of PCR, primers P1, T7 primer (5’- TAA TAC GAC TCA 
CTA TAG GGA GAC-3’) and P2 (5’-ATG ATG ATG ATG ATG ATG GGG AGA TCT GGC CGG 
CTG-3’) were allowed to introduce hexahistidine coding sequence at the 3’ end of the PCR fragment. 
Similarly, primers P3 (5’-CAT CAT CAT CAT CAT CAT CGG CTG CAG GTC GAC GAAC-3’) 
and primers P4, BGH reverse primer (5’-CTA GAA GGC ACA GTC GAG GC-3’) were enable to 
generate an overlapping region of hexahistidine coding sequence at the 5’end. pDisplay as template 
was used for two reactions. The two PCR amplified DNA fragments were then used as templates for 
the second round of PCR with primers P1 and P4. Plasmid pFLAG CMV-neuregulin containing 
cDNA
6
 for EGF domain of mouse neuregulin are preserved in our laboratory. The construct of 
His-EGF-TD was made as follows. The cDNA fragments of EGF were amplified by PCR from 
pFLAG CMV–neuregulin using primer P1 (5’- GCGTCGAC TCA AAC GCC ACA TCT ACA 
TCC-3’) and P2 (5’-GCGTCGAC CTC CTC CGC TTC CAT AAA TTC-3’) which introduced a 
SalI restriction enzyme sites at the 5’- and 3’- (bold) ends. The amplified PCR product was ligated 
into TA vector and then confirmed sequence was subcloned into SalI site of His-pDisplay. 
 
Cell application using His-tagged membrane protein expressed Cos-7 cells 
Cos-7 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 g/ml streptomycin. All items 
were purchased from GIBCO (USA). The cells were cultured at 37
o
C in a humidified 5% CO2 
atmosphere. Cos-7 cells were seeded at 7x10
4
 cells onto the 35 mm glass bottom dishes containing 
2 ml fresh culture medium and transfected with the plasmid (0.5 g) of His-EGF-TD using 
Effectene reagent (Qiagen, USA) according to the protocol. After 1 or 2 days, the cells were washed 
twice with Hank’s balanced salt solution (HBSS) (GIBCO, USA) and stained at room temperature 
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by treating with either dyes as described in the Figure legend or His6 Ab (see Materials and 
Methods) at room temperature. His6 Ab stock solution (0.1 mg/ml) was diluted 1:20 into DMEM 
with 10% FBS and added to the cells for 15 min. The cells were washed twice with HBSS and 
stained with Alexa Fluor-633 secondary antibody (see Materials and Methods) at a 1:300 dilution of 
the stock solution (2 mg/ml) for 15 min.  Then the cells were washed twice with HBSS and 
imaged with a laser-scanning confocal microscope (Olympus FV1000) under 60 x oil lenses. 
 
Immunoblotting 
Cells were washed with phosphate buffer saline (PBS, 10 mM phosphate, 150 mM sodium 
chloride, pH 7.2) and lysed in sodium dodecyl sulfate (SDS) buffer (100 mM Tris pH 6.8, 2% SDS, 
15% glycerol and 0.1 mM dithiothreitol (DTT)). After scrapping the cells from the dishes, samples 
were homogenized and boiled at 95
o
C for 5 min. 10 g of samples and 4x sample buffer (0.26 M 
Tris-HCl, pH6.8, 40% glycerol, 16% SDS, 0.08 mg/ml bromophenol blue, and 100 mM DTT) were 
diluted to 1x and were loaded per well. The samples were separated by SDS gel electrophoresis and 
transferred to polyvinylidenefluoride (PVDF) membranes, blocked with 5 % skim milk in Tween 20 
Tris buffered saline (TBST) (150 mM NaCl, 0.05 % Tween 20, and 20 mM Tris-HCl, pH7.4), and 
probed with His6 Ab. The membrane was incubated with an anti-mouse secondary antibody 
conjugated with HRP at a 1:20000 dilution for 1.5 h. Then the blotting was detected with an ECL 
reagent. 
 
Cell application using HeLa cells 
HeLa cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 g/ml streptomycin. All items 
were purchased from GIBCO (USA). The cells were cultured at 37
o
C in a humidified 5% CO2 
atmosphere. For cell viability test, HeLa cells were seeded at 1.0 x 10
4
 cells onto the 96 well plate 
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and cultured 24 hours. Each sample was added to each well and incubated another 6 or 24 hours. 
The viability of the cell was checked by tetrazolium salts (WST-8) assays.  
 
Cell application using HEK293 cells expressing His-tagged CFP 
HEK293 cells expressing His-tagged CFP were purchased from Gentarget Inc. (USA). 
HEK293 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 2 mM L-glutamine, 10% fetal bovine serum (FBS), 0.1 mM MEM non-essential amino acid 
and 100 U/ml penicillin and 100 g/ml streptomycin. All items were purchased from GIBCO (USA). 
The cells were cultured at 37
o
C in a humidified 5% CO2 atmosphere. Freeze-thaw lysis was 
performed by freezing in a dry ice/ethanol bath, thawing in a 37°C water bath. Supernatant was 
collected after centrifugation (14,000 x g, 15min) and purified by using a HisTrap (GE Healthcare) 
according to the manual. Concentration of the purified His-tagged CFP was determined by the 
absorbance ( = 26000 (M-1cm-1)) 7. 
 
3. Results and Discussions 
The complex of Dabcyl-His6 and TMR-TriNTA/3 Ni
2+
 was used to examine whether the 
system functions in living cells. First of all, His-tagged membrane protein was exploited for 
evaluation of “turn-on” property. When Cos-7 cells transfected with His-EGF-TD were incubated 
with only TMR-TriNTA/3 Ni
2+ 
or the complex with Dabcyl-His6, the fluorescent intensity was 
measured before and after washing, with dye-free HBSS, respectively. As expected, compared to 
only TMR-TriNTA/3 Ni
2+
 before washing, the quencher complex appeared to reduce the 
non-specific fluorescence emitted by the dye absorbed on the background, which was similar to the 
one through the washing process with HBSS (Figure 1A). 
The fluorescence intensity of TMR-TriNTA/3 Ni
2+
 dissociated from the complex with the 
quencher was similar to the one incubated with the TMR-TriNTA/3 Ni
2+
 only on single cell level 
 - 64 - 
 
as shown in Figure 1B “S (surface)”, indicating that the exchange between Dabcyl-His6 and a 
His-tagged protein should occur on the cell membrane efficiently.  In addition, the signals shown 
inside cells were significantly reduced as compared to the one that was treated with 
TMR-TriNTA/3 Ni
2+
 only (p<0.01) (Figure 1B “I (inside)”).  It was assumed that the signal 
observed inside of the cell would result from only TMR-TriNTA/3 Ni
2+
 penetrating through the 
cell, partially.  On the other hand, the complex with Dabcyl-His6 might prevent the penetration of 
the dye inside the cell, resulting in reduction of the signal due to the inside signal. 
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Figure 1. “Turn-on system” reduces non specific absorption. (A) Cos-7 cells transfected with 
His-EGF-TD were incubated with TMR-TriNTA/3 Ni
2+
 or complex of TMR-TriNTA/3 Ni
2+
 and 
Dabsyl-His6. Images were captured before wash (upper half) and after wash with HBSS (lower 
half9) using Olympus confocal microscope. All panels were subjected to identical confocal setup. 
Bar, 10 m (B) The intensity of fluorescence was measured both S (surface) and I (inside) of cells. 
Data are expressed as means ± S.E.M of 6 to 9 each cell chosen from three different experiments. * 
p<0.01 compared to dye only by unpaired two-tailed t-test. 
 
 As a next step, TAT peptide which is well known as a cell penetrating peptide
1
 was 
introduced to Dabcyl-His6 to accelerate the membrane permeability of a “turn-on” probe (Figure 2).  
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The fluorescence spectrum of TMR-TriNTA/3 Ni
2+
, before and after addition of an equimolar 
amount of Dabcyl-His6-TAT, was measured to determine the extent of fluorescence quenching. 
When an equimolar amount of Dabcyl-His6-TAT was added to a solution of 1 M 
TMR-TriNTA/3 Ni
2+
, 20 mM Tris-HCl (pH 7.4), the fluorescence intensity of the solution 
decreased to 12% of its initial value (Figure 3a). The fluorescence intensity returned to a level of 
33% (2.8-fold increase) after ten times molar excess of His6 was added (Figure 3b). This 
fluorescence enhancement indicated that Dabcyl-His6-TAT had also been partially displaced from 
TMR-TriNTA/3 Ni
2+
.  
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Figure 2. Chemical structure of TAT introduced dabcyl-conjugated peptide. 
 
Figure 3. Fluorescent spectra of 1 M TMR-TriNTA/3 Ni2+ in Tris-HCl (pH 7.4) (ex = 500 nm). 
(a) before and after addition of an equimolar amount of Dabcyl-His6-TAT, and (b) before and after 
addition of His6 to the Dabcyl-His6-TAT -containing solution of Figure 3(a).  
 
 Then, this “turn-on” fluorescent probe was applied to a cultured cell. The cytotoxicity of 
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the probe was evaluated by using HeLa cells. As shown in Figure 4, there was almost no 
cytotoxicity up to 10 M concentration of a fluorescent probe within 24 hours. The concentration 
and incubation time are enough for the protein labeling. To evaluate the detail of the “turn-on” 
fluorescent property in living cell, HeLa cells were incubated with the complex of TMR-TriNTA/3 
Ni
2+ 
and Dabcyl-His6. Then, the fluorescent intensity was measured before and after addition of 
aetoxymethylated EGTA (EGTA-AM) which is a cell-permeant chelator. After addition of 
EGTA-AM, strong fluorescent was observed in the cell compared to without EGTA-AM (Figure5). 
This result indicated that almost of the “turn-on” probe can penetrate the cell membrane keeping its 
complex (OFF state) because the fluorescent intensity of the complex of Dabcyl-His6-TAT and 
TMR-TriNTA/3 Ni
2+
 was increased in the presence of EGTA result from dissociation of the 
complex.   
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Figure 4. Cell viability was investigated by tetrazolium salts (WST-8) assays. HeLa cells were 
incubated for 6 and 24 hours in the presence of each compounds.  
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(A)
(B)
 
Figure 5. HeLa cells were incubated 3 hrs with the complex of Dabcyl-His6-TAT (1 M) and 
TMR-TriNTA/3 Ni
2+ 
(1 M). Images were captured in the absence (A) and presence (B) of 
EGTA-AM. 
 
 To compare the cell membrane permeability with or without TAT peptide, the fluorescent 
intensity was measured after incubation with the “turn-on” probes. HeLa cells were incubated with 
the complex of Dabcyl-His6 and TMR-TriNTA/3 Ni
2+ 
, Dabcyl-His6-TAT and TMR-TriNTA/3 
Ni
2+
 for 1, 3, 6 and 12 hours, respectively. After treatment with EGTA-AM, fluorescent intensity of 
each cells were measured. As shown in Figure 6, the complex of Dabcyl-His6-TAT and 
TMR-TriNTA/3 Ni
2+
 was delivered into the cell effectively compared to the complex without TAT 
peptide.  
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Figure 6. HeLa cells were incubated with the complex of (A)Dabcyl-His6 (1 M) and 
TMR-TriNTA/3 Ni
2+ 
(1 M), (B)Dabcyl-His6-TAT (1 M) and TMR-TriNTA/3 Ni2+ (1 M). 
Images were captured after each incubation time (1-12 hours). Scale bar is 200 m. 
 
Finally, HEK 293 cells expressing His-tagged CFP were used for the analysis of intracellular 
His-tagged protein labeling. To investigate whether fluorescence resonance energy transfer (FRET) 
was occurred between His-tagged CFP and TMR-TriNTA/3 Ni
2+
, the cell lysate was prepared by 
freeze-thaw cycles and purified by using a Ni
2+
 affinity chromatography. Excitation and emission 
spectra of the purified His-tagged CFP and TMR-TriNTA/3 Ni
2+
 were measured. Overlap between 
emission spectrum of CFP and excitation spectrum of TMR-TriNTA/3 Ni
2+
 was confirmed (Figure 
7(A)). Then, fluorescent spectra before and after addition of TMR-TriNTA/3 Ni
2+ 
into the 
His-tagged CFP solution were measured by using a 440 nm excitation wavelength. After addition of 
TMR-TriNTA/3 Ni
2+
, fluorescent intensity at 500 nm was decreased and 550 nm was increased 
(Figure 7(B)). Additionally, there was no quenching at 500 nm in the absence of Ni
2+ 2
. These result 
indicated that FRET was occurred between His-tagged CFP and TMR-TriNTA/3 Ni
2+
. At last, to 
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evaluate the intracellular His-tagged protein labeling with a “turn-on” fluorescent probe, HEK293 
cells expressing His-tagged CFP were incubated with the complex of Dabcyl-His6-TAT and 
TMR-TriNTA/3 Ni
2+
 for 3 hours. After removing the excess fluorescent probe, fluorescent 
intensity of each cell were measured with a laser-scanning confocal microscope under 60 x oil 
lenses. As shown in Figure 8(C), His-tagged CFP was expressed anywhere in the each cell. Intensity 
of TMR-TriNTA/3 Ni
2+ 
was detected by using 440 nm and 559 nm lasers. 440 nm excitation image 
of TMR-TriNTA/3 Ni
2+
 (Figure 8 (F)) showed fluorescence signal and colocalized with the image 
by using excitation at 559 nm (Figure 8 (B)), however, some signal is missing in the 440 nm 
excitation image. These result indicated that some of the “turn-on” probe showed nonspecific 
dissociation of quencher-conjugated histidine peptide and gave a fluorescence signal which didn’t 
show FRET from CFP to TMR. On the other hand, most of the fluorescent signal colocalized with 
both 440 nm and 559 nm excitation images. This result also suggested that most of the “turn-on” 
probe was able to label the intracellular His-tagged CFP, effectively. 
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Figure 7. (A) Excitation and emission spectra of His-tagged CFP and TMR-TriNTA/3 Ni
2+
 in 
Tris-HCl (pH 7.4) (His-tagged CFP : em = 500 nm,ex = 440 nm, TMR-TriNTA/3 Ni
2+
 : em = 575 
nm,ex = 500 nm). (B) Before (solid line) and after (dashed line) addition of 3.5 M 
TMR-TriNTA/3 Ni
2+
 to the 0.35 M His-tagged CFP-containing solution.  
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(A) (B) (C) (D)
(E) (F) (G) (H)
 
Figure 8. Fluorescence imaging of HEK293 cells incubated with the complex of Dabcyl-His6-TAT 
(1 M) and TMR-TriNTA/3 Ni2+ (1 M). (A)(E) Differential interference contrast image. (B) Ex: 
440 nm and 559 nm, Em: 570-670 nm. (C) Ex: 440 nm and 559 nm, Em: 485-535 nm. (F) Ex: 440 
nm, Em: 570-670 nm. (G) Ex: 440 nm, Em: 485-535 nm. (D)(H) The overlay image of (B) and (C), 
(F) and (G), respectively. Scale bar is 10 m. 
 
4. Summary 
In conclusion, the fluorescent “turn-on” system in response to a His-tagged protein 
expressed cells were demonstrated. When the complex of His-tag target probe and the 
complementary quencher-peptide was exposed with a His-tagged protein expressed on the cell 
membrane, the complexes was dissociated under an equilibrium state with the tagged protein, 
resulting in the fluorescence emitted by the dye while the uninvolved fluorescent probe remained as 
a quenched state. In addition, the complex with TAT introduced quencher-conjugated peptide 
showed high cell membrane permeability keeping its complex (OFF state). Additionally, this 
complex was able to label the intracellular His-tagged CFP. This system should be attractive in the 
field of a microarray system because the washing process wastes time to remove free dye. In 
addition, this system should possess a high potentiality for the application to the intracellular protein 
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labeling where are difficult to be washed. 
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1. Conclusions 
 In this thesis, the author describes about development of small molecular fluorescent 
probes for protein labeling, in particularly, intracellular protein. The important knowledge obtained 
from respective study is summarized below. The author is convinced that small molecular 
fluorescent probes will be more attractive tools to investigate the basic biological science and drug 
discovery. 
 
1. The mass spectroscopic screening method identified an asymmetric ligand with high affinity 
for a hexahistidine tag from a pooled library of mixed ligands synthesized by click chemistry.  
The convenient gas phase analysis using an ion trap revealed that the stability of the complex in 
the gas phase agreed with the dissociation rate constant in solution. Therefore, this method 
opens up the possibility of performing a powerful high-throughput screening of ligands for 
biological applications. (Chapter 2) 
 
2. A “turn-on” fluorescent probe system for which the fluorescent receptor is “turned-on” when 
the bound quencher is replaced by a His-tagged protein. By optimizing suitable combinations 
of receptor and ligand, similar systems could also be used for various applications such as 
single molecule imaging and multicolor imaging in living cells. (Chapter 3) 
 
3. Photo-cross linker introduced fluorescent probe was designed and synthesized. After UV 
irradiation, the results of the evaluation of molecular weight and diffusion time showed this 
probe was able to bind to His-tag moiety covalently. Additionally, this probe worked as a 
“turn-on” fluorescent probe by combination of quencher-conjugated histidine peptide. (Chapter 
4) 
 
4. In conclusion, the fluorescent “turn-on” system in response to a His-tagged protein expressed 
cells were demonstrated. When the complex of His-tag target probe and the complementary 
quencher-peptide was exposed with a His-tagged protein expressed on the cell membrane, the 
complexes was dissociated under an equilibrium state with the tagged protein, resulting in the 
fluorescence emitted by the dye while the uninvolved fluorescent probe remained as a 
quenched state. In addition, the complex with TAT introduced quencher-conjugated peptide 
showed high cell membrane permeability keeping its complex (OFF state). Additionally, this 
complex was able to label the intracellular His-tagged CFP. This system should be attractive in 
the field of a microarray system because the washing process wastes time to remove free dye. 
In addition, this system should possess a high potentiality for the application to the intracellular 
protein labeling where are difficult to be washed. (Chapter 5) 
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2. Future Prospects 
Screening of a novel combination of peptide-tag and small molecule 
 As described in chapter 2, ligand-target non-covalent interactions are readily examined 
without the need to purify each ligand by using a collision activated dissociation (CAD) method 
based on ion trap ESI-MS. This methodology is applicable to search a novel combination of 
peptide-tag and small molecule. Although the combinations of peptide-tag and small molecule have 
been reported, the choice is limited only four kinds of peptide-tag. The variety of this combination 
will be important and effective for multi staining of the target protein toward various applications. 
 
Construction of various functional “turn-on” probes 
 As described in chapter 3, the author constructed “turn-on” fluorescent probe system 
utilizing quencher-conjugated peptide. In this system, the selection of fluorophore and target 
peptide sequences will not be limited. In this reason, not only the various fluorescent colored 
fluorophore but also functional fluorophore which can detect the change in the cell condition (e.g. 
ions, viscosity and temperature) will applicable to this “turn-on” system.  
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